Who was studied, and how
Three numbers in the abstract
Where each one falls
Where it lands on the map
Already taking canagliflozin, or nottheir own situation, not assigned
Canagliflozin went with lower HHF−61%
No clear link with BKLE amputation−25%
correlation, not a testthe abstract, start to end
… HHF with canagliflozin vs non-SGLT2i was 0.39 (95% CI, 0.26-0.60) in the …
… with canagliflozin vs non-SGLT2i was 0.75 (95% CI, 0.40-1.41) in the on-treatment analysis and 1.01 (95% CI, 0.93-1.10) in the …